AZD1043 Clinical Trials (2026): 1 Studies for Healthy Participants & Obesity
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 AZD1043 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy Participants & Obesity) and 104 total planned enrollment. 1 AZD1043 clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT07511205 (Nov 2027).
Where to Participate: All AZD1043 Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting AZD1043trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Research Site | Glendale91206 | NCT07511205 | Map |
AZD1043 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting AZD1043 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07511205 | A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. | P1 | Healthy Participants | 104 | Mar 2026 |
All AZD1043 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07511205 | A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity. | P1 | recruiting | 104 | AstraZeneca | Mar 2026 |
AZD1043 clinical trials: frequently asked questions
- How many AZD1043 clinical trials are there?
- 1 AZD1043 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are AZD1043 clinical trials recruiting in 2026?
- Yes — 1 AZD1043 trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is AZD1043 being studied for?
- AZD1043 is being studied for Healthy Participants, Obesity. The trials are grouped by indication on this page.
- What phase is AZD1043 in?
- AZD1043 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors AZD1043 clinical trials?
- The lead sponsor across the most AZD1043 trials is AstraZeneca. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming AZD1043as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: